Epothilone derivative for the treatment of hepatoma and other cancer diseases

Details for Australian Patent Application No. 2003227702 (hide)

Owner Novartis AG

Inventors Rothermel, John David

Agent Davies Collison Cave

Pub. Number AU-B-2003227702

PCT Number PCT/EP03/04581

PCT Pub. Number WO2003/092683

Priority 60/377,063 01.05.02 US

Filing date 30 April 2003

Wipo publication date 17 November 2003

Acceptance publication date 26 July 2007

International Classifications

C07D 277/24 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/425 (2006.01) - Thiazoles

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 60/377,063 01.05.02 US

8 January 2004 Application Open to Public Inspection

  Published as AU-B-2003227702

26 July 2007 Application Accepted

  Published as AU-B-2003227702

22 November 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003227703-Method for tamper-proof identification of products

2003227701-CAST IRON TILE AND METHOD FOR THE PRODUCTION OF CAST IRON TILE